Blood‐based biomarker for identifying post‐mortem confirmed Cerebral Amyloid Angiopathy
Alpana Singh, Marisa N. Denkinger, Kari Dieckhoff, James Liu et autres
BACKGROUND: Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder characterized by the deposition of amyloid-β (Aβ) in the walls of leptomeningeal and cortical blood vessels leading to increased risk of microbleeds, intracerebral hemorrhages, and progressive cognitive decline. It is estimated that up …
us (code pays fourni par la source)
0 citations
Alzheimer s & Dementia